Open three-stage transthoracic oesophagectomy versus minimally invasive thoraco-laparoscopic oesophagectomy for oesophageal cancer: protocol for a multicentre prospective, open and parallel, randomised controlled trial
Juwei Mu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie He(Third People's Hospital of Hangzhou), Yongtao Han(Sichuan Cancer Hospital), Shugeng Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Bin Qiu(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhao-ke Wen(The People's Hospital of Guangxi Zhuang Autonomous Region), Mingxin Shi(Nantong Tumor Hospital), Tiansheng Yan(Peking University), Yousheng Mao(Chinese Academy of Medical Sciences & Peking Union Medical College), Deruo Liu(Roswell Park Comprehensive Cancer Center), Kun Yang(Sichuan University), Quan Xu(Beijing Tsinghua Chang Gung Hospital), Ning Li(Nanjing University of Chinese Medicine), Rongyu Xu(Hangzhou First People's Hospital), Wenxiang Wang(Oil Crops Research Institute), Hui Li(Yuncheng University), Ming Du(The Affiliated Yongchuan Hospital of Chongqing Medical University), Shun Xu(First Hospital of China Medical University), Qi Xue(Chinese Academy of Medical Sciences & Peking Union Medical College), Kai Su(Sun Yat-sen University), Zuyang Yuan(Chinese Academy of Medical Sciences & Peking Union Medical College), Ke‐Neng Chen(Peking University), Fang Lv(Liaoning Normal University)
Cited by 23
Related Papers
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2023|1k
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415